Nabriva Therapeutics plc Accrued Liabilities, Current
Nabriva Therapeutics plc had Accrued Liabilities, Current of $11.98 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-10-19
- 2023-06-30: Accrued Liabilities, Current $11.98M.
- 2023-03-31: Accrued Liabilities, Current $20.82M.
- 2022-12-31: Accrued Liabilities, Current $17.34M.
- 2022-09-30: Accrued Liabilities, Current $12.01M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-06-30 | $11.98M 10-Q · filed 2023-10-19 | |
| 2023-03-31 | $20.82M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $17.34M 10-Q · filed 2023-10-19 | |
| 2022-09-30 | $12.01M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $11.63M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $10.50M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $13.83M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $15.09M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $15.24M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $11.29M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $12.84M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $8.93M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $8.38M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $9.93M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $11.97M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $11.66M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $11.20M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $10.53M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $14.50M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $10.30M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $8.36M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.58M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $8.12M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $11.01M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $8.43M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $11.55M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $13.33M 10-K · filed 2018-03-16 | $13.31M 10-K · filed 2017-03-24 |
| 2015-12-31 | $5.82M 10-K · filed 2017-03-24 |